课题基金 / 基金详情

PURINE/PYRIMIDINE METABOLISM IN TRICHOMONAS AND GIARDIA

PURINE/PYRIMIDINE METABOLISM IN TRICHOMONAS AND GIARDIA
毛滴虫和贾第虫中的嘌呤/嘧啶代谢
批准号:
3128773
负责人:
Ching Chung WANG
金额:
$21.34万
依托单位国家:
美国
项目类别:
财政年份:
1982
资助国家:
美国
项目状态:
已结题
起止时间:
1982-08-01 至 1990-07-31

项目摘要

项目成果

Ching Chung WANG的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Three anaerobic protozoan parasites, Giardia Lamblia, Trichomonas vaginalis and Tritrichomonas foetus, which all grow naturally by adhering to host epithelial cells and performing phagocytosis, have been found lacking the capability of de novo synthesis of purine and pyrimidine nucleotides and deficient in dihydrofolate reductase and thymidylate synthetase activities. They depend on rather simple salvage pathways for purines, pyrimidines and nucleosides. These pathways, delineated by us during the past two years, have presented several pivotal enzymes which not only are essential for survival of these parasites but also exhibit unique substrate specificities qualifying themselves as potential targets of antiparasitic chemotherapy. These enzymes are the APRT, GPRT and UPRT in G. lamblia, HXGPRT, UPRT and IMPDH in T. foetus and the deoxyribonucleoside phosphotransferase of T. vaginalis. The GPRT, HXGPRT and IMPDH have been purified to homogeneity and shown to have many different properties from the related host enzymes. We are planning on a screening program for inhibitors of these isolate enzymes as one way of finding chemotherapeutic agents. On the other hand we will prepare pure samples of G. lamblia GPRT, T. foetus HXGPRT, T. foetus IMPDH and mouse sarcoma 180 IMPDH in microgram quantities by the established procedures. The N-terminal sequences of the four purified enzymes will be determined, the corresponding oligonucleotides will be synthesized and used as probes to begin identifications, clonings and sequencings of the genes encoding these enzymes for sequence comparisons. It is anticipated that sequence differences associated with the enzyme active sites may explain the different substrate specificities and help new drug designs. Meanwhile, further purifications of the UPRT's and the T. vaginalis deoxyribonucleoside phosphotransferase will be pursued with affinity column chromatographies. An exciting observation of the presence of a double-stranded RNA in T. vaginalis, the discovery of the RNA gene in T. vaginalis DNA and the possible relationship between the RNA and the metronidazole-sensitivity of T. vaginalis will lead us into further pursue of these new findings. Genomic libraries of T. vaginalis will be established and the double-stranded RNA will be used as a probe to initiate the identification, cloning and sequence determination of its encoding genome for further understanding of the biological function of the double-stranded RNA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: PEDIATRIC STUDY OF SODIUM PHENYLBUTYRATE W/TYPE II/III SPINAL MU
  • 批准号:
    7717950
  • 项目类别:
  • 资助金额:
    $0.09万
  • 财政年份:
    2007
  • 负责人:
    Ching Chung WANG
  • 依托单位:
Purine Metabolism in Trichomonas vaginalis
Purine Metabolism in Trichomonas vaginalis
Purine Metabolism in Trichomonas vaginalis
海外基金